Skip To Main Content
Ashley Akbari on Muck Rack

Ashley Akbari

As seen in: Color Research & Application, Nature, Wiley, Wiley Online Library, PLOS ONE, Archives of Disease in Childhood, BMJ Open, MDPI, Thorax, The Lancet and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ashley

Contact Ashley, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Creating a Research-Ready Data Asset version of primary care data for Wales and investigating the impact of COVID-19 on utilisation of primary care services

|
By Hoda Abbasizanjani, Stuart Bedston, Ashley Akbari
| PLOS ONE
Discussion This study describes the development of the WLGP RRDA, a curated and structured version of primary care data for Wales designed to improve analytic readiness, consistency, and scalability of research using WLGP data within the SAIL Databank. The RRDA enables more efficient use of routinely collected primary care data by applying methodical cleaning, code mapping, and normalisation techniques tailored to the Welsh healthcare context.
Open in Who Shared Issue with article?

Health and care service utilisation in the last year of life before non-sudden death in Wales, 2014-2023, by palliative care registration: a population-based retrospective cohort study - The Lancet Regional Health - Europe

|
By Rhiannon K. Owen, Helen Daniels, Ashley Akbari, Elinor Curnow
| The Lancet Verified
Keywords Palliative care End of life Healthcare utilisation Care home Electronic health records Routine data Administrative data Evidence before this study We searched PubMed and relevant citations on February 20, 2025 using the search terms ((health service utilisation [Title/Abstract]) OR (health care utilisation [Title/Abstract]) OR (pathway [Title/Abstract])) AND ((end of life [Title/Abstract]) OR (last year of life [Title/Abstract]) OR (palliative care [Title/Abstract])) AND...
Open in Who Shared Issue with article?

Anti‐thrombotic therapy in patients with cancer at the end of life: A cohort study using population‐linked routinely collected data

|
By Sarah Aldridge, Ashley Akbari, Adrian Edwards, Kate J Lifford
| Wiley Online Library Verified
INTRODUCTION Approximately 30%–50% of people with cancer are prescribed anti-coagulants and anti-platelet agents, collectively termed anti-thrombotic therapy (ATT), but little is known about the balance of their benefits and harms in the context of malignancy.1-3 Most patients are already receiving ATT at the time of cancer diagnosis for arterial thromboembolism (ATE) such as cardiovascular, cerebrovascular and peripheral vascular disease or as stroke prevention for atrial fibrillation or...
Open in Who Shared Issue with article?
See all 41 licensed articles (42 Total)